Imagine an invention machine that is capable of analysing all published human scientific knowledge and then extrapolating forward. If this invention machine were then to publish its own predictions of, say, future materials, hypothetical drug compounds, or improved cell-based therapies, could this prevent future innovations from being patented?
What is new?
Novelty is the first hurdle of patentability for an invention and relies on a fairly objective assessment: either the invention has been disclosed to the public before the filing date, or it hasn’t. Novelty is assessed against anything that is published either in writing, online or even disclosed orally, such as in a public meeting or presented at a conference. Novelty is examined by looking at the claims of the patent application and comparing them against everything made available to the public before the earliest filing date (the so-called priority date). If the subject matter of the claims has been described already in the